Crop Protection Partnerships

FMC Expands Fluindapyr Fungicide Access Through Strategic Agreement with Corteva

FMC Corporation reported fourth quarter 2024 revenue of $1.22 billion, representing a 7% increase compared to the same quarter in 2023.

Key Takeaways

  • FMC Corporation and Corteva Agriscience have entered a strategic agreement to expand the reach of fluindapyr fungicide technology in the U.S. corn and soybean markets.
  • Both companies will independently market fluindapyr-based products to growers across key regions.
  • Fluindapyr targets foliar diseases such as tar spot and southern rust, with properties designed to manage fungicide-resistant pathogens.
  • Corteva will launch its fluindapyr-based product in the 2026 growing season, subject to EPA approval.
  • The agreement is part of FMC’s broader strategy to commercialize fluindapyr in multiple international markets.

FMC and Corteva Collaborate on Fungicide Access for U.S. Growers

FMC Corporation (NYSE: FMC), a global player in agricultural sciences, has announced a strategic agreement with Corteva Agriscience (Profile) to broaden access to its fluindapyr fungicide across the U.S. corn and soybean sectors. The deal marks a significant step in extending the availability of the novel active ingredient, which has demonstrated efficacy against key foliar diseases that impact crop yield.

“This strategic agreement will introduce FMC’s innovative fluindapyr technology into a broader segment of the U.S. corn and soybean markets, which represent roughly 95 million and 80 million planted acres, respectively,” said Ronaldo Pereira, President of FMC. “By partnering with Corteva, we’re providing more growers with access to the advanced tools they need to effectively combat costly and challenging diseases.”


Market Availability and Product Plans

Under the agreement, both companies will commercialize fungicides that utilize fluindapyr. FMC will continue marketing its existing Adastrio® fungicide, while also working on additional formulations. Corteva Agriscience plans to introduce its fluindapyr-based product at the start of the 2026 U.S. growing season, pending regulatory approval from the Environmental Protection Agency.

“Fluindapyr offers a new tool for disease resistance management and yield protection,” noted Jeremy Dirks, President of Corteva North America. “With the novel active ingredient, fluindapyr, we can provide growers with an additional effective disease management tool that complements the other fungicides in our portfolio.”

Fluindapyr belongs to Group 7 under the Fungicide Resistance Action Committee (FRAC) classification and is valued for its residual control and ability to address resistance issues in pathogens.


Global Reach and Future Launches For FMC

While the agreement primarily targets the U.S. corn and soybean markets, FMC has already introduced fluindapyr-based products in countries including Argentina, Brazil, Colombia, Mexico, Paraguay, South Korea, and the United States. Additional launches are anticipated in Chile, Honduras, India, and Ukraine, contingent on regulatory decisions.

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

5 Comments

Leave a Reply